Spilk S, Herr MD, Sinoway LI, Leuenberger UA. Endothelium-derived hyperpolarizing factor contributes to hypoxia-induced skeletal muscle vasodilation in humans. Am J Physiol Heart Circ Physiol 305: H1639 -H1645, 2013. First published September 16, 2013 doi:10.1152/ajpheart.00073.2013.-Systemic hypoxia causes skeletal muscle vasodilation, thereby preserving O 2 delivery to active tissues. Nitric oxide (NO), adenosine, and prostaglandins contribute to this vasodilation, but other factors may also play a role. We tested the hypothesis that regional inhibition of endothelium-derived hyperpolarizing factor with the cytochrome P-450 2C9 antagonist fluconazole, alone or combined with the NO synthase antagonist N G -monomethyl-L-arginine (L-NMMA), attenuates hypoxia-induced vasodilation. We compared forearm blood flow (FBF) and skin blood flow before and during brachial artery infusion of fluconazole (0.3 mg/min; trial 1) or fluconazole ϩ L-NMMA (50 mg over 10 min; trial 2) and during systemic hypoxia (10 min, arterial PO 2 ϳ37 mmHg) in infused (experimental) and control forearms of 12 healthy humans. During normoxia, fluconazole and fluconazole ϩ L-NMMA reduced (P Ͻ 0.05) forearm vascular conductance (FVC) by ϳ10% and ϳ18%, respectively. During hypoxia and fluconazole (trial 1), FVC increased by 1.76 Ϯ 0.37 and 0.95 Ϯ 0.35 units in control and experimental forearms, respectively (P Ͻ 0.05). During hypoxia and fluconazole ϩ L-NMMA (trial 2), FVC increased by 2.32 Ϯ 0.51 and 0.72 Ϯ 0.22 units in control and experimental forearms, respectively (P Ͻ 0.05). Similarly, during hypoxia with L-NMMA alone (trial 3; n ϭ 8) FVC increased by 1.51 Ϯ 0.46 and 0.45 Ϯ 0.32 units in control and experimental forearms, respectively (P Ͻ 0.05). These effects were not due to altered skin blood flow. We conclude that endotheliumderived hyperpolarizing factor contributes to basal vascular tone and to hypoxia-induced skeletal muscle vasodilation and could be particularly relevant when other vasodilator systems are impaired.hypoxia; vasodilation; endothelium-derived hyperpolarizing factor; fluconazole; nitric oxide UNDER BASAL CONDITIONS and during physiological stress, skeletal muscle blood flow is closely matched to metabolic demand. Accordingly, in healthy humans, systemic hypoxia is accompanied by skeletal muscle vasodilation, which serves to maintain O 2 homeostasis (20,27,29). Because hypoxia raises sympathetic vasoconstrictor nerve traffic and norepinephrine spillover (14, 31), vasodilation results from release of systemic or local vasodilator factors. In agreement with studies in rodents (22,24,26), it has been reported that nitric oxide (NO) (7,9,16,35) and adenosine (15, 18) contribute to hypoxiainduced vasodilation in humans. In addition, some reports (6, 35), but not others (27), support a role for an increase in circulating epinephrine, and one recent report (19) suggests that vasodilator prostaglandins also contribute to the skeletal muscle vasodilation elicited by systemic hypoxia. Thus multiple endogenous vasodilator mechanisms ...